| |
| |
|
| Insider
Information: |
Caforio Giovanni |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
434,821 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,244,614 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
434,821 |
|
|
| Total
Value |
$20,244,614 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
| Percentage
Gain/Loss : |
0.0%
|
 1.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
Executive Chair of the... |
2024-03-10 |
432,266 |
|
0 |
Premium* |
|
|
Stryker Corp |
SYK |
Director |
2023-05-10 |
2,555 |
2023-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
Executive Chair of the Board |
• • – |
2024-03-10 |
4 |
D |
$53.79 |
$3,648,199 |
D/D |
(67,823) |
432,266 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Executive Chair of the Board |
• • – |
2024-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(57,536) |
479,917 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Executive Chair of the Board |
• • – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
190,130 |
529,662 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2023-10-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
440 |
367,495 |
0 |
- |
|
| SYK |
Stryker Corp |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
705 |
2,555 |
0 |
- |
|
| SYK |
Stryker Corp |
Director |
– • – |
2023-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
841 |
1,850 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2023-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
35,144 |
448,529 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
234,676 |
431,381 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2023-03-10 |
4 |
D |
$65.71 |
$9,067,257 |
D/D |
(137,989) |
367,935 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2023-02-06 |
4 |
S |
$74.65 |
$17,916,000 |
D/D |
(240,000) |
236,104 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-09-20 |
4 |
AS |
$69.71 |
$1,742,750 |
D/D |
(25,000) |
476,104 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-09-15 |
4 |
S |
$71.84 |
$3,592,000 |
D/D |
(50,000) |
501,104 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-03-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
420 |
581,104 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-03-21 |
4 |
AS |
$71.52 |
$1,788,000 |
D/D |
(25,000) |
581,524 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-03-10 |
4 |
D |
$68.42 |
$10,871,254 |
D/D |
(158,890) |
606,524 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
239,501 |
653,392 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
72,458 |
712,285 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-02-24 |
4 |
S |
$67.00 |
$2,010,000 |
D/D |
(30,000) |
453,455 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2021-09-20 |
4 |
AS |
$60.64 |
$1,516,000 |
D/D |
(25,000) |
483,980 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2021-08-02 |
4 |
S |
$68.58 |
$1,371,600 |
D/D |
(20,000) |
508,980 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2021-03-22 |
4 |
AS |
$62.20 |
$1,555,000 |
D/D |
(25,000) |
528,980 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2021-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
22,035 |
619,061 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2021-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
200,709 |
603,187 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2021-03-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,635) |
473,453 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2021-03-10 |
4 |
D |
$60.93 |
$6,838,357 |
D/D |
(112,233) |
553,980 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
